Cita APA

Farias, A., Soto, A. S., Puttur, F., Goldin, C. J., Sosa, S., Gil, C., . . . Berguer, P. M. (2021). A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment. Web

Citación estilo Chicago

Farias, Ana, Ariadna Soledad Soto, F. Puttur, Carla Jimena Goldin, Santiago Sosa, C. Gil, Fernando Alberto Goldbaum, and Paula Mercedes Berguer. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment By Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. 2021.

Cita MLA

Farias, Ana, et al. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment By Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. 2021.